Sandra Surbrugg, MD
Dermatology · Cheyenne, WYNPI 1699742957
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.7% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 23.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $576 and has fallen 96.8% since, to $19 in 2025.
Across 98 payments — averaging $18.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$427
- AbbVie$410
- Sanofi-aventis U.S. LLC$172
- Sun Pharmaceutical Industries Inc.$114
- DUSA Pharmaceuticals, Inc.$107
- Amgen$105
- plus $514 from 13 others
What the payments were for
- Food & beverage$1,67691%
- Education$1729%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 26 | $427 |
| AbbVie(2 entities) | 25 | $410 |
| Sanofi-aventis U.S. LLC | 2 | $172 |
| Sun Pharmaceutical Industries Inc. | 5 | $114 |
| DUSA Pharmaceuticals, Inc. | 5 | $107 |
| Amgen | 6 | $105 |
| Regeneron Healthcare Solutions, Inc. | 4 | $84 |
| Lilly USA, LLC | 5 | $83 |
| Galderma Laboratories, L.p. | 4 | $60 |
| Sanofi | 3 | $56 |
| Biofrontera Inc. | 2 | $42 |
| LEO Pharma Inc. | 2 | $41 |
| Bristol Myers Squibb | 2 | $33 |
| Genentech USA, Inc. | 2 | $29 |
| VYNE Pharmaceuticals Inc. | 1 | $25 |
| Boehringer Ingelheim | 1 | $16 |
| Verrica Pharmaceuticals Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $15 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $13 |
How this compares
Too few dermatology providers in Wyomingto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Calcipotriene | 18 | $2,295 |
| Clobetasol Propionate | 26 | $1,733 |
| Metronidazole | 20 | $1,290 |
| Fluorouracil | 13 | $878 |
| Hydroxychloroquine Sulfate | 11 | $434 |
| ValacyclovirValacyclovir Hcl | 11 | $282 |
| Triamcinolone Acetonide | 29 | $244 |
| Mupirocin | 24 | $225 |
| Ketoconazole | 15 | $175 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Cheyenne
- Krystal MasseyCheyenne$9K
- Gregory SeitzCheyenne$2K
- Julie NevilleCheyenne$1K
- Mary ColeCheyenne$957
- Samuel EckerLaramie$3K
- Tyler QuestCasper$2K
- Matthew GreenCasper$2K
- Scott BennionCasper$2K
- Melissa RhoadesGillette$2K
- Jonathan BakerJackson$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.